Maxygen Inc.
This article was originally published in Start Up
Executive Summary
Combinatorial Biology. Maxygen, founded by Alejandro Zaffaroni, PhD, is selecting randomly reassembled fragments of DNA for specific properties of the enzymes they produce. Glaxo Wellcome owns more than half of the equity in Maxygen.